SCHEMBL105264

SCHEMBL105264

CC(C)c1cccc(C(=O)O)c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 1/20 0.66
RXRB P28702 1/20 0.66
RXRG P48443 1/20 0.66
ANPEP P15144 1/20 0.58
ENPEP Q07075 1/20 0.58
MRGPRX4 Q96LA9 1/20 0.54
MAPT P10636 3/20 0.53
SMN1; SMN2 Q16637 3/20 0.53
PTGS1 P23219 3/20 0.53
PTGS2 P35354 3/20 0.53
HPGD P15428 3/20 0.53
CXCR1 P25024 2/20 0.53
CXCR2 P25025 2/20 0.53
KDM4E B2RXH2 2/20 0.53
ALDH1A1 P00352 2/20 0.53
CYP3A4 P08684 2/20 0.53
HSD17B10 Q99714 2/20 0.53
RECQL P46063 1/20 0.53
LMNA P02545 1/20 0.53
MAPK1 P28482 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30444032 1.00 RXRA (0.66) RXRARXRBRXRGANPEPENPEP
Hydrochloric Acid SCHEMBL27676992 0.98 RXRA (0.64) RXRARXRBRXRGANPEPENPEP
SCHEMBL10455036 0.93 RXRA (0.68) RXRARXRBRXRGANPEPENPEP
SCHEMBL4970909 0.89 RXRA (0.55) RXRARXRBRXRGANPEPENPEP
SCHEMBL4602193 0.89 RXRA (0.78) RXRARXRBRXRGMRGPRX4LMNA
SCHEMBL371525 0.88 ANPEP (0.58) RXRARXRBRXRGANPEPENPEP
SCHEMBL30354039 0.88 ANPEP (0.58) RXRARXRBRXRGANPEPENPEP
Isophthalic Acid SCHEMBL25190289 0.86 ANPEP (0.56) RXRARXRBRXRGANPEPENPEP
SCHEMBL14843614 0.86 ANPEP (0.56) RXRARXRBRXRGANPEPENPEP
Hydrogen Peroxide SCHEMBL9061056 0.86 RXRA (0.54) RXRARXRBRXRGMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 571 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117659230-A Polyvinyl ether end-capping method and application 中国石油化工股份有限公司 2024-03-08 CN claimed
US-20190002447-A1 BIFUNCTIONAL MOLECULES WITH ANTIBODY-RECRUITING AND ENTRY INHIBITORY ACTIVITY AGAINST THE HUMAN IMMUNODEFICIENCY VIRUS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2019-01-03 US claimed
US-7951765-B2 Photoresist stripper composition for semiconductor manufacturing TECHNO SEMICHEM CO., LTD. (KR) 2011-05-31 US claimed
EP-1913448-B1 PHOTORESIST STRIPPER COMPOSITION FOR SEMICONDUCTOR MANUFACTURING TECHNO SEMICHEM CO LTD (KR) 2010-10-13 EP claimed
US-20090312216-A1 Photoresist Stripper Composition for Semiconductor Manufacturing TECHNO SEMICHEM CO., LTD. (KR) 2009-12-17 US claimed
EP-1913448-A4 PHOTORESIST STRIPPER COMPOSITION FOR SEMICONDUCTOR MANUFACTURING TECHNO SEMICHEM CO LTD (KR) 2008-11-05 EP claimed
EP-1913448-A1 PHOTORESIST STRIPPER COMPOSITION FOR SEMICONDUCTOR MANUFACTURING Techno Semichem Co., Ltd. (KR) 2008-04-23 EP claimed
WO-2007021085-A1 PHOTORESIST STRIPPER COMPOSITION FOR SEMICONDUCTOR MANUFACTURING TECHNO SEMICHEM CO., LTD. (KR) 2007-02-22 WO claimed
EP-4737449-A1 P53-Y220C SELECTIVE SMALL-MOLECULAR REACTIVATOR COMPOUND, PHARMACEUTICAL COMPOSITION AND USE THEREOF Changchun Genescience Pharmaceutical Co., Ltd. (CN) 2026-05-06 EP disclosed
US-20250381187-A1 KRAS G12C INHIBITORS AND METHODS OF USING THE SAME AMGEN INC. (US) 2025-12-18 US disclosed
US-20250305210-A1 FIBER-TREATING AGENT KAO CORPORATION (JP) 2025-10-02 US disclosed
US-12414949-B2 Pyrazolyl pyrimidinone compounds and the uses thereof PURDUE RESEARCH FOUNDATION (US) 2025-09-16 US disclosed
EP-4559918-A2 GLUCOSYLCERAMIDE SYNTHASE INHIBITORS Genzyme Corporation (US) 2025-05-28 EP disclosed
EP-3673906-B1 GLUCOSYLCERAMIDE SYNTHASE INHIBITORS GENZYME CORP (US) 2025-05-14 EP disclosed
WO-2001074811-A2 SUBSTITUTED 1,3-THIAZOLE COMPOUNDS, THEIR PRODUCTION AND USE TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-10-11 WO disclosed
EP-0339887-B1 Process for the preparation of indigo compounds MITSUI TOATSU CHEMICALS (JP) 1996-07-10 EP disclosed
EP-0507576-A1 Polypropylene-based resin compositions TOSOH CORPORATION (JP) 1992-10-07 EP disclosed
US-4973706-A OXIDATION OF INDOLE WITH HYDROPEROXIDE MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1990-11-27 US disclosed
EP-0339887-A1 Process for the preparation of indigo compounds MITSUI TOATSU CHEMICALS, Inc. (JP) 1989-11-02 EP disclosed
US-4062904-A Removal of hydroxyl-, carboxy-, or amino substituents from aromatic compounds using a group VI B catalyst UOP INC. (US) 1977-12-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12414949-B2 Pyrazolyl pyrimidinone compounds and the uses thereof CAP1, ADCY1, ADCYAP1R1 RXRA 2685/4885RXRB 2580/4885RXRG 2660/4885
US-20190002447-A1 BIFUNCTIONAL MOLECULES WITH ANTIBODY-RECRUITING AND ENTRY INHIBITORY ACTIVITY AGAINST THE HUMAN IMMUNODEFICIENCY VIRUS CD4, HAVCR2, CD2 RXRA 4638/4885RXRB 4629/4885RXRG 4420/4885
US-20250381187-A1 KRAS G12C INHIBITORS AND METHODS OF USING THE SAME KRAS, NRAS, HRAS RXRA 2927/4885RXRB 2633/4885RXRG 1815/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.